← Eichor
Study identifier: NCT06585852 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid (RGD) in Horizontal Ridge Augmentation With Split-crest Technique for Implant Placement

Condition: Implant Dentistry  ·  Sponsor: Al-Azhar University

PhaseNA
Planned participants18
Who can joinAll sexes, 18 Years to 30 Years
Healthy volunteersYes

About this study

The aim of the present study is to evaluate the efficacy of xenograft alone or xenograft mixed with Arginylglycylaspartic acid (RGD) , in horizontal ridge augmentation with split-crest technique, for implant placement.

This description comes directly from the study's public registry record.

Talk to the study team

Mahmoud Taha, PHD  ·  01225864104  ·  info@azhar.edu.eg

Ibrahim Sabri  ·  01007809113  ·  info@azhar.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Al Azhar University of CairoCairo, Nasr City, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06585852